Jian-Qiang Tan
Biographic Data
| ID | 7972855 |
|---|---|
| NAME | Jian-Qiang Tan |
| GIVEN NAMES | Jian-Qiang |
| FAMILY NAME | Tan |
| SIGNATURE | TAN J |
| AFFILIATIONS | Guangzhou Medical University |
| VERIFIED | No |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Our exploratory, post-hoc analysis of an open-label, single-arm study suggests that patients with depression and a higher baseline BMI may experience greater reductions in depressive symptoms compared with those with a lower baseline BMI after receiving six ketamine infusions
A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
After six ketamine infusions, the improvement of anhedonic symptoms was found in both patients with melancholic and non-melancholic depression, and the efficacy was similar in both groups
Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
The rates of antianhedonic response and remission to multiple ketamine infusions for the treatment of depression were similar between males and females. These findings should be verified by future studies, preferably randomized controlled trials (RCTs)
No prominent works on this page.
A comparison of the antianhedonic effects of repeated ketamine infusions in melancholic and non-melancholic depression
After six ketamine infusions, the improvement of anhedonic symptoms was found in both patients with melancholic and non-melancholic depression, and the efficacy was similar in both groups
Gender differences in the antianhedonic effects of repeated ketamine infusions in patients with depression
The rates of antianhedonic response and remission to multiple ketamine infusions for the treatment of depression were similar between males and females. These findings should be verified by future studies, preferably randomized controlled trials (RCTs)
Body mass index is associated with the antidepressant effects of intravenous ketamine in patients with depression
Our exploratory, post-hoc analysis of an open-label, single-arm study suggests that patients with depression and a higher baseline BMI may experience greater reductions in depressive symptoms compared with those with a lower baseline BMI after receiving six ketamine infusions
Anesthesia (3 works) · Depression (economics (3 works) · Ketamine (3 works) · Medicine (3 works) · Psychiatry (3 works) · Psychology (3 works) · Treatment of Major Depression (3 works) · Tryptophan and brain disorders (3 works) · Clinical Psychology (2 works) · Clinical Psychology (2 works)